COPIED
3 mins

NEXT UP

Claudia McGloin asks: what should really define the next trend in regenerative injectables?

If you work in aesthetics long enough, you quickly learn that there is always a “next big thing”. Regenerative aesthetics is no different. PRP, PRF, polynucleotides, exosomes, biostimulators and complex combination treatments are now competing for attention in a rapidly expanding market.

I am all for innovation, but after many years working with PRP and regenerative treatments, I have become increasingly cautious about confusing new with better.

Innovation is how medicine progresses, but adopting something simply because it is new is very different from adopting it because there is a sound clinical reason to do so. With regenerative treatments in particular, terminology can be persuasive. The word “regenerative” suggests repair, restoration and biological improvement, but describing a treatment as regenerative does not automatically mean regeneration is occurring.

So perhaps instead of asking what is trending, we should be asking some more fundamental questions.

Those questions may not be the most exciting questions when a new product launches, but they are the questions that should determine whether a treatment becomes part of our clinical practice.

COMBINATION REGENERATIVE TREATMENTS

One trend I do think we will continue to see is the growth of combination regenerative treatments. We are moving away from relying on one injectable or one modality to address everything and towards combining treatments with different proposed mechanisms of action.

There is logic to this. Ageing is multifactorial. Hair loss is multifactorial. Tissue quality, vascularity, inflammation, cellular function and the underlying health of the patient can all influence what we are trying to achieve. It makes sense that one intervention may not address every component.

But combination therapy should not simply mean adding more treatments.

When combining PRP with another injectable, device or regenerative modality, I want to understand what each contributes, the evidence or biological rationale for the combination, the optimal sequencing and any additional risks.

Without those questions, combination therapy can very quickly become treatment stacking.

NEWER DOES NOT MEAN BETTER

PRP itself provides a useful example of why newer does not necessarily mean better. Despite being one of the more established regenerative treatments, we are still refining our understanding of it.

We still talk about PRP as though it were one treatment, when two practitioners can take blood from two different patients, use two different preparation systems and produce biologically very different products. Platelet concentration, leucocyte content, red blood cell contamination, processing and activation can all vary. That is before we even consider the indication, injection technique or perhaps the greatest variable of all, the patient.

If we have not yet completely standardised how we describe and use one of our most established regenerative treatments, we should perhaps be cautious about how quickly we embrace the next one.

PROFESSIONAL RESPONSIBILITY

There is also a professional responsibility that comes with introducing new injectable treatments. Learning how to inject a product is only one part of being competent to offer it. We need to understand what we are using, the evidence behind it, appropriate indications and contraindications, patient selection, consent, potential complications and what we will do when something does not go according to plan.

Marketing should never move faster than competence.

Perhaps this is where the real trend in regenerative aesthetics needs to occur.

Instead of continually asking, “What is the next injectable?”, perhaps we should be asking, “What represents genuine progress?”

Sometimes that will be a new product. Sometimes it will be a new combination or a better understanding of how existing treatments can work together. But progress can also mean becoming more selective, questioning claims, recognising when the evidence is not yet sufficient and using the regenerative treatments we already have more intelligently.

The treatments that ultimately become established clinical practice should not be those that generate the most attention or the greatest hype. They should be the treatments that withstand scrutiny, have a clear clinical rationale and ultimately demonstrate value for our patients.

The future of regenerative injectables should not be defined by what is newest.

It should be defined by what improves patient outcomes.

CLAUDIA MCGLOIN

Claudia McGloin is a registered nurse with dual registration in Ireland and the UK and over 28 years of clinical nursing experience. An orthopaedic nurse practitioner specialising in PRP and regenerative medicine, she works across regenerative aesthetics, musculoskeletal medicine and patient optimisation. Claudia is an international speaker, educator and an Aesthetic Medicine editorial contributor.

This article appears in Nov/dec 2026

Go to Page View
This article appears in...
Nov/dec 2026
Go to Page View
DEAR READERS
There’s always something new to talk about in
MEET THE EXPERTS
The Aesthetic Medicine editorial board’s clinical expertise and diverse range of specialities help ensure the magazine meets the needs of the readers. In this issue, we have received guidance from the following members:
SKIN QUALITY REDEFINED
As skin quality becomes an increasingly prominent focus in aesthetic practice, Teoxane introduces babyGLOW™ and babyGLOW™ for HIM, two protocols designed to address skin revitalisation with a focus on precision and natural-looking results. 1
HOT OFF THE PRESS
UK government launches consultation on high-risk cosmetic procedures
OUT & ABOUT
REJURAN PRESS TRIP Seoul and Gangneung, South Korea
JEN VITTANUOVA IS… LEGALLY AESTHETIC
Funny, frank and fiercely attached to her patients, Jen Vittanuova is bringing her experience as an aesthetic nurse and expert witness into education. With Legally Blonde as her muse, she is making the case for better consent, sharper records and safer clinics, discovers Kezia Parkins .
CASE STUDY: CHRONIC ACNE AND SCARRING TRANSFORMATION
Treating chronic acne and post-acne concerns with a personalised combination approach
PDRN VS PN: WHAT AESTHETIC PRACTITIONERS NEED TO KNOW
As PDRN moves into topical skincare and injectable polynucleotides gain prominence in clinics, confusion surrounding the two categories is growing. Ellen Cummings examines their proposed mechanisms, evidence and implications for clinical practice.
BEYOND THE SURFACE
A multi-layer approach to skin rejuvenation with RF Microneedling
NEXT UP
Claudia McGloin asks: what should really define the next trend in regenerative injectables?
THE EVOLVING BOOB JOB
Consultant plastic surgeon Paul Banwell on awake surgery, tissue preservation, implant innovation and the future of the “boob job”.
BEYOND THE TEMPLATE
Dr Ahmed El Muntasar argues that safe, individualised aesthetic care requires practitioners to understand anatomical variation, assess skin characteristics and question whose beauty standards shape treatment.
CLINIC TO COSMETIC COUNTER
Dr Farah Latif and Prof Ali Al -Hussaini ask: are professional treatments becoming beauty products?
UNDERSTANDING ICHTHYOSIS VULGARIS
Dr Kemi Fabusiwa and Professor Edel O’Toole explain how to recognise, manage and treat ichthyosis vulgaris, from protecting the skin barrier to supporting patients with long-term care.
RETHINKING THE RESEARCH
Dr Jordan Faulkner on why practitioners need to question the evidence behind the treatments they offer.
PRACTICALLY PERFECT?
As Practical Magic 2 hits cinemas, 28 years after the original, its female stars have ignited a debate around ageing: don’t have too much work done, but don’t show any signs of ageing. Vicky Eldridge asks: how can women in aesthetic medicine help to change the narrative?
PRECISION FIRST
Emma Wedgwood looks into why the next big thing in 2027 will not be a treatment, but precision.
WHEN TRENDS TRAVEL FASTER than governance
From glass skin to treatment stacking, South Korea is shaping patient expectations. But does faster adoption mean better practice? Jen Vittanuova explores what UK aesthetics can learn, and why clinical judgement must keep pace with innovation.
THE UNSEEN WORK OF EXCELLENCE
Why clinical excellence depends on consistent standards, practical experience and knowing when to keep learning.
THE PURSUIT OF EXPERTISE OR THE PURSUIT OF RECOGNITION?
Amy Bird questions whether aesthetic medicine is prioritising visibility and recognition over clinical knowledge.
LEAD WITH THE CONDITION NOT THE CURE
Why condition-led websites win more consultations and keep you on the right side of the ASA.
ASK THE EXPERTS
Which health factors could influence treatment outcomes?
THE INTELLIGENT CLINIC
Dr Askari Townshend looks into why the future of aesthetics will be driven by data.
HOW AI SEARCH IS CHANGING WHERE PATIENTS FIND AESTHETIC CLINICS
AI is changing how patients discover aesthetic clinics. Panita Vig explains what AI search means for clinic visibility and the practical steps practitioners can take now to stay discoverable.
RETHINKING CLINICAL STYLE
Ditching the traditional clinical look, Emma Wedgwood shares how she transformed her treatment room into a space that reflects her style and personality.
PROTECT YOUR PRACTICE
Asking the right questions now can help protect your practice, reputation and clients later,
HYDRAFACIAL NANO-NEEDLING
Connie Cooper visited the Hydrafacial flagship to try their latest treatment: Hydrafacial Deluxe with SkinStylus Nano-Needling.
DOUBLE CHIN TIGHTENING WITH XERF
Contributing reporter Anna Dobbie visits the Seriderm Training Centre to experience XERF, a non-invasive radiofrequency treatment that tightens and firms the skin beneath her chin.
PRODUCT NEWS
AlumierMD AlumierMD has expanded its Biocellulose range with
5 MINUTES WITH ... IAIN DE HAVILLAND
Founder of NADclinic Group, Iain De Havilland discusses evolution of NAD+ therapy and the growing role of personalised longevity medicine in aesthetics.
5 ANATOMY EXPERTS TO FOLLOW
These five specialists are putting facial anatomy, clinical knowledge and education at the forefront of aesthetics.
Looking for back issues?
Browse the Archive >

Previous Article Next Article